NeuroMolecular Pharmaceuticals' Other Investors

NeuroMolecular Pharmaceuticals raised a round of funding on , . Investors include Takeda Ventures.

NeuroMolecular Pharmaceuticals is developing and commercializing superior neuroprotective medicines for the treatment of central nervous system (CNS) disorders. The Company has built a robust pipeline…

Articles about NeuroMolecular Pharmaceuticals' Other Investors: